Shots: Navrogen expands its collaboration with Levena to develop ADCs targeting humoral immuno-suppressed cancers The collaboration will deploy Levena’s linker and cytotoxic payload chemistry expertise with Navrogen’s cancer-targeting Abs discovered […]readmore
